Masaru Enomoto

8PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 16, 2026
Trends in the Proportion of Hepatitis C Virus Antibody-Positive Patients Who Could be Considered for Direct-Acting Antiviral Therapy Identified Through Preoperative Testing for Ophthalmic Surgery: A Nationwide Multicenter Real-World Cohort Study in Japan.

|May 18, 2026
Evolving Strategies in HBV Management: Insights From Updated International Guidelines.

|Sep 28, 2022
Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms.

Truong Huu Hoang, Misako Sato-Matsubara, Hideto Yuasa

|Sep 17, 2020
Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivation.

Akihiro Tamori, Kiminori Kimura, Kiyohide Kioka

|Mar 01, 2019
Switching to tenofovir disoproxil fumarate vs continuing treatment in patients with chronic hepatitis B who maintain long-term virological response to entecavir therapy: A randomized trial.

Ayako Iida-Ueno, Masaru Enomoto, Ritsuzo Kozuka

|Nov 03, 2018
Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C.

Masaru Enomoto, Yoshihiro Ikura, Akihiro Tamori

Pageof 2

Frequent Collaborators

2 joint publications

Akihiro Tamori

1 joint publications

Yoshihiro Ikura

1 joint publications

Kiminori Kimura

1 joint publications

Truong Huu Hoang